Our study expands the current literature by also demonstrating a role for TEAD1 in GBM migration, using both in silico and functional analyses, the latter involving stable CRISPR-Cas9-mediated knockout of TEAD1/4 in primary GBM cultures. The gene discussed is TEAD1; the disease is glioblastoma.